New guidelines expand on psychosocial, sexual health, cognitive and other issues
Consensus conference begins work on new recommendations for clinical care and research
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New BMT leadership looks to clinical research and cell therapy production to overcome treatment access limitations
Physicians shares insights about screening, supportive care and potential therapies in development
A 12-year-old patient and others in clinical trial are cured of sickle cell disease thanks to half-match donors
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
A closer look at how social determinants of health affect outcomes
Treating sickle cell disease sometimes takes a village